Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program (Q48030944)

7 February 2018

title

Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program (English)

1 reference

7 February 2018

main subject

cervix uterine cancer

1 reference

Nadia Demarteau

1

1 reference

7 February 2018

Thomas Breuer

series ordinal

2

1 reference

7 February 2018

Baudouin Standaert

series ordinal

3

1 reference

7 February 2018

publication date

1 April 2012

1 reference

7 February 2018

published in

PharmacoEconomics

1 reference

7 February 2018

volume

30

1 reference

7 February 2018

issue

4

1 reference

7 February 2018

page(s)

337-353

1 reference

7 February 2018

Burden of cervical cancer in Europe: estimates for 2004.

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Chapter 8: Screening for cervical cancer in developing countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Chapter 1: HPV in the etiology of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

21 January 2018

HPV vaccine: Cervarix

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Economic evaluation of human papillomavirus vaccination in developed countries

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Modeling cervical cancer prevention in developed countries

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Cost-effectiveness of vaccination against cervical cancer: a multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination scenarios.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Critical issues in the economic evaluation of interventions against communicable diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Optimal allocation of resources across four interventions for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Efficiency, equity, and budgetary policies: informing decisions using mathematical programming.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Mathematical programming for the efficient allocation of health care resources.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Allocating HIV prevention resources: a tool for state and local decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Addressing the challenges to immunization practice with an economic algorithm for vaccine selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Integer/linear mathematical programming models: a tool for allocating healthcare resources.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

HPV and cervical cancer in the 2007 report

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Cervical cancer screening following prophylactic human papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: a multi-regional health economic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591560-000000000-00000

Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression

21 January 2018

1 reference

12 December 2020

A linear programming model for allocating HIV prevention funds with state agencies: a pilot study

1 reference

12 December 2020

Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions

1 reference

12 December 2020

National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008.

1 reference

12 December 2020

The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies

1 reference

12 December 2020

Incremental cost-effectiveness ratios (ICERs): the silence of the lambda

1 reference

12 December 2020

10.2165/11591560-000000000-00000

Identifiers

DOI

1 reference

7 February 2018

Dimensions Publication ID

1026060384

0 references

Fatcat ID

release_eyb6rf6z6jgx3i5qvcbv2a4xs4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eyb6rf6z6jgx3i5qvcbv2a4xs4

24 November 2022

mapped directly with Wikidata item

1 reference

7 February 2018